Drug Profile
FGY 1153
Alternative Names: FGY-1153Latest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Class Analgesics; Eye disorder therapies
- Mechanism of Action Bradykinin B1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Retinal disorders
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for preclinical development in Retinal-disorders in Hungary
- 26 Aug 2017 Preclinical trials in Retinal disorders in Hungary
- 26 Aug 2017 Pharmacodynamics data from a preclinical trial in Retinal disorders presented at the Annual Congress of the European Society of Cardiology (ESC-2017)